by Adrian Manz | Aug 4, 2026 | The Doctor's Dose
SpaceX Targets $1 Trillion in Annual Revenue by 2030—but Investors Want to See the Math SpaceX CEO Elon Musk has moved one of the most ambitious corporate growth targets on Wall Street forward by a year, telling investors that SpaceX expects to generate $1 trillion in...
by Julie Manz | Aug 4, 2026 | The Doctor's Dose
Performance Insight The Trader’s Performance Edge with Dr. Julie Manz Because the most important edge you will ever develop is not in the market. It is in yourself. Welcome to Performance Insight. There are thousands of books, courses and tools designed to help people...
by admin | Aug 4, 2026 | The Doctor's Dose
The AI Profitability War: Why China’s Low-Cost Models Could Reshape the Entire AI Trade For nearly three years, investors have focused on one question: Who will build the most powerful artificial intelligence models? That question is beginning to change. The...
by Adrian Manz | Aug 3, 2026 | The Doctor's Dose
SpaceX Faces Its First Major Test as a Public Company SpaceX will release its first earnings report as a public company after Tuesday’s closing bell, giving investors their first detailed look at the financial machinery behind one of the most heavily promoted—and most...
by Adrian Manz | Aug 3, 2026 | The Doctor's Dose
Dow Closes at Record as Iran Talks Ignite Rally: What Traders Should Watch Tuesday Wall Street began the week with a powerful risk-on move as renewed hopes for diplomacy between the United States and Iran sent oil prices lower, Treasury yields down, and technology...
by Adrian Manz | Aug 3, 2026 | The Doctor's Dose
Micron Shares Rebound as China’s CXMT Plans Major Memory-Chip Expansion Micron Technology shares reversed early losses Monday as the broader semiconductor sector recovered, but the long-term competitive picture for the U.S. memory-chip producer may be growing more...
by Adrian Manz | Aug 2, 2026 | The Doctor's Dose
The Everything Pill? Why GLP-1 Drugs May Be Healthcare’s Biggest Investment Story After AI Artificial intelligence may dominate today’s headlines, but another revolution is quietly transforming healthcare—and it could become one of the biggest long-term...
by Adrian Manz | Aug 1, 2026 | The Doctor's Dose
SpaceX Stock Tumbles as Starship Heat Shield Questions Add to Investor Concerns SpaceX shares continued their dramatic post-IPO slide Friday, falling to another record low as investors grapple with lofty valuation expectations, upcoming insider lockup expirations, and...
by Adrian Manz | Aug 1, 2026 | The Doctor's Dose
Universal Music Stock Plunges 25% as Streaming Growth Slows and AI Concerns Rise Universal Music stock suffered one of its worst trading sessions since becoming a publicly traded company, plunging 25% after disappointing quarterly results raised new concerns about the...
by Adrian Manz | Jul 31, 2026 | The Doctor's Dose
Big Tech AI Investment Tops $1.1 Trillion as Investors Demand Returns Big Tech AI investment has crossed a staggering new threshold as Google, Amazon, Microsoft and Meta commit unprecedented amounts of capital to data centers, advanced chips, cloud infrastructure and...
